TMCnet News
BioCryst Celebrates Bob Ingram's Contributions to the Company's SuccessRESEARCH TRIANGLE PARK, N.C., March 29, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today acknowledged the many contributions of Robert A. Ingram, the company’s chairman of the board, who recently passed away. We are very saddened by his loss and our thoughts and prayers go to Bob’s wife Jeanie and his sons Cameron, Michael and Rory. Bob served as a board member since 2015 and chairman since 2017 and played a central role in recruiting highly accomplished board members who brought a wide diversity of skills. He set a tone of transparency with management that created a highly effective relationship that has led to some of the most productive years in the company’s history. “Bob Ingram has directly affected millions of lives through his leadership, support and development of new medicines throughout his career. We are grateful for his leadership of our board, and the gracious wisdom he always shared with us,” said board member Dr. Nancy Hutson on behalf of the BioCryst board of directors. About BioCryst Pharmaceuticals BCRXW Contact: ![]() |